Company Announces Appointment of Daniel Flynn, Ph.D. and Brian Cali, Ph.D. to Strengthen Capabilities in Support of Company’s Peptide Drug

Investment strengthens Argonaut’s leadership position in sterile fill / finish and expands the Company’s aseptic drug product manufacturing capabilities in

Pleasanton, California – February 7, 2024 – n6 Tec Inc., a next generation sequencing and molecular biology platform company, announced

iconPCR enables optimal high-throughput PCR for next generation sequencing and molecular biology applications PLEASANTON, CA – February 6, 2024— n6

Panome Bio adds deep, unbiased proteomics to their proprietary metabolomics platform to deliver innovative multi-omics services REDWOOD CITY, Calif., Nov.

Positions the Company as a new leader in providing solutions that bridge the gap between cellular electrophysiology and advanced analysis

ST. LOUIS, March 15, 2023 /PRNewswire/ — Panome Bio, a metabolomics and proteomics services company that provides biopharma innovators unparalleled

VENLO, The Netherlands & SAN DIEGO–(BUSINESS WIRE)– QIAGEN (NYSE:QGEN; Frankfurt Prime Standard: QIA) today announced it has completed the acquisition of

Madison, WI USA, January 5, 2023–/BusinessWire/ — Nimble Therapeutics, a biotechnology company leveraging its next-generation peptide discovery platform to identify

MADISON, WI, USA, December 13, 2022 — Nimble Therapeutics Inc., a leading peptide therapeutics company, today announced they have achieved